Vivo Opportunity Fund, L.P.'s Net Worth
$0
Estimate Recalculated Sep 17, 2024 06:50PM EST
Who is Vivo Opportunity Fund, L.P.?
Vivo Opportunity Fund, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sierra Oncology, Inc., Crinetics Pharmaceuticals, Inc., ALX ONCOLOGY HOLDINGS INC, Kadmon Holdings, Inc., Bolt Biotherapeutics, Inc., and Terns Pharmaceuticals, Inc..
SEC CIK
Vivo Opportunity Fund, L.P.'s CIK is 0001726403
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $50.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.02% | -528.00 |
$19.50 | -$10,296.00 | 3.27M |
Mar 9
| |||
Form 4
| -0.21% | -13.46K |
$21.70 | -$291,587.00 | 6.54M |
Feb 7 - Feb 10
| |||
Form 4
| -0.41% | -13.46K |
$22.80 | -$306,888.00 | 3.28M |
Feb 4
| |||
Form 4
| -0.27% | -26.92K |
$22.00 | -$594,164.00 | 9.9M |
Jan 29 - Jan 31
| |||
Form 4
| -11.16% | -417.00K |
$22.25 | -$9,278,250.00 | 3.32M |
Mar 20
| |||
Form 4
| +59.34% | 3.74M |
$17.65 | $6,575,421.40 | 10.04M |
Jul 20
| |||
| No matching records found | |||||||||
Kadmon Holdings, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bolt Biotherapeutics, Inc. (BOLT) Snapshot price: $0.641
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8,933.46% | 3.83M |
$16.57 | $2,995,480.00 | 3.87M |
Feb 9
| |||
| No matching records found | |||||||||
Terns Pharmaceuticals, Inc. (TERN) Snapshot price: $7.99
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.68M |
$17.00 | $6,075,001.00 | 2.68M |
Feb 9
| |||
| No matching records found | |||||||||
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.33% | 800K |
$27.00 | $21,600,000.00 | 2.74M |
Jan 31
| |||
Form 4
| +31.95% | 612.44K |
$13.20 | $8,084,168.40 | 2.53M |
Jan 26
| |||
Form 4
| +3,045.01% | 1.86M |
—
|
—
| 1.92M |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||